Alembic Pharmaceuticals Limited is one of the leading pharmaceutical companies in India, engaged in the development of formulations and active pharmaceutical ingredients (APIs). Established in 1907, the company boasts expertise in synthetic chemistry, formulation development, and solid oral dosage form manufacturing. Alembic operates a state-of-the-art R&D facility that focuses on API process developments, process chemistry, generic formulation development, novel drug delivery systems, and bioequivalence studies. Its manufacturing facilities are approved by regulatory authorities including USFDA, EDQM, German FDA, TGA, KFDA, MHRA, TPD, MCC, COFEPRIS, and ANVISA.

Services include:
– APIs (Active Pharmaceutical Ingredients)
– Generic formulation development
– Novel drug delivery systems
– Bioequivalence studies

Alembic Pharmaceuticals Limited remains committed to advancing pharmaceutical solutions, focusing on anti-infective, analgesic, and cough and cold therapies. For more information, please visit alembic-india.com.